Boris Rudic
Papers
1
Total Citations
12
H-Index
1
About
Boris Rudic is a leading figure in the emerging field of cardiac radioablation, where his work bridges radiation oncology and electrophysiology to treat life-threatening ventricular tachycardia. His most impactful contribution is his central role in the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial, a landmark multicenter study that established critical benchmarks for treatment planning across multiple platforms. His 2022 paper on this benchmarking, which has garnered 12 citations, provides the foundational methodology for standardizing cardiac radioablation—a non-invasive alternative to traditional catheter ablation. Rudic’s research addresses the complex challenge of targeting moving cardiac tissue with high-dose radiation while sparing surrounding organs, a problem he has tackled through rigorous dosimetric comparisons and interdisciplinary collaboration. His work has directly influenced clinical protocols, enabling more precise and safer treatments for patients with refractory arrhythmias. By harmonizing approaches across institutions, Rudic has accelerated the translation of this novel therapy from experimental to practical application, making him a key architect in the evolution of non-invasive cardiac care.
Research Focus
Key Achievements
Top Papers
- 1